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Abstract 
Purpose: To synthesis a series of novel thiazolo pyrimidine derivatives and evaluate them in vitro for 
their safety and  anthelmintic activity against E. multilocularis metacestodes using BALB/c mice. 
Methods: A new series of substituted amino thiazole, hydrazinothiazole and thiazolo pyrimidine 
derivatives (2-6) were synthesized by reaction of compound 1 with potassium isothiocyanate to give 
the corresponding compound 2, which was used as starting material. The physicochemical 
characterization of these derivatives was carried out by nuclear magnetic resonance spectroscopy 
(1HNMR) and mass spectroscopy (MS).The purity of the compounds was determined by elemental 
analysis. Safety and anthelminthic activity of the compounds against E. multilocularis metacestodes 
was evaluated in vitro by i) viability assessment and relative abundance of 14-3-3 mRNA determination 
in E. multilocularis metacestodes-suspensions treated with 2, 5 and 10 µM concentrations of each 
compound separately.  ii) bioassay  at 15 weeks post-inoculation of mice by E. multilocularis 
suspensions-treated with 30 µM albendazole (ABZ), 10 µM thiazolopyrimidine derivative 5 (TPYDa) 
and a combination of both. Liver functions of all mice were tested before mice sacrifice.  
 Results: TPYDa emerged as the active anthelmintic compound of the series against E. multilocularis 
metacestodes viability (activity, 60 %) compared with ABZ (activity, 63 %). When TPYDa was 
combined with ABZ, the activity reached 86 %. No mortality was found and liver function was normal in 
all mice during the studies.  
Conclusion: The compound, TPYDa, can serve as a lead molecule for further development to a 
clinically useful novel class of anthelmintic agents. 
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Hepatic echinococcosis is a life-threatening 
disease, mainly differentiated into alveolar and 
cystic forms, associated with Echinococcus 
multilocularis (E. multilocularis) and 
Echinococcus granulosus (E. granulosus) 
infection respectively.  Cystic Echinococcosis 
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(CE) has a worldwide distribution, while hepatic 
Alveolar Echinococcosis (AE) is endemic in the 
Northern hemisphere, including North America, 
several Asian and European countries [1]. In 
human patients, E. multilocularis forms 
multilocular metacestodes that exhibit growth 
and/or proliferation of metacestodes over a long 
period of time leads to the development of 
space-occupying lesions, causes organ 
dysfunction, and can occasionally lead to death 
[2].  
 
Benzimidazole carbamate derivatives such as 
albendazole and mebendazole are currently the 
drugs of choice. For treatment of AE, 
benzimidazole treatment has been shown to act 
parasitostatic rather than parasitocidal for many 
cases, and the recurrence rates after 
interruption of therapy in not radically operated 
cases are higher [3]. Thus, new options for 
chemotherapy are needed, anticipating a 
parasitocidal activity if possible. 14-3-3 proteins 
are found in all eukaryotic cells and participate in 
protein signaling pathways. They function as 
phosphoserine/phosphothreonine-binding 
modules and have an effect on phosphorylation-
dependent events, such as DNA-damage 
checkpoints and prevention of apoptosis [4].  
Some 14-3-3 proteins have been shown to be 
aberrantly expressed in tumor cells, acting either 
pro- or anti-tumorogenic and there are a number 
of similarities between cancer cells and some 
parasites, particularly echinococcus [5]. 
Similarities include features such as the 
essentiality unlimited proliferative capacity of 
protoscoleces/brood capsules, the potential to 
modulate the immune response, the secretion of 
proteolytic enzymes to reach their target sites or 
organs, and the formation of metastases [6]. E. 
multilocularis metacestodes behave like 
malignant tumors, over-expression in 
metacestodes of 14-3-3 proteins. Indeed, when 
echinoccocus 14-3-3 sequences are aligned in 
metacestodes group with the tumor-growth 
related zeta-isoforms of neoplastic mammalian 
cells [7].  
 
 New synthesized thiazolopyrimidine (TPYD) 
derivatives; hetero-cyclic compounds were 
found to possess a variety of pronounced 
activities such as anti-parkinsonism, 
hypoglycemic, antimicrobial activities [8] anti-
inflammatory, analgesic [9-10], anti-avian 
influenza virus (H5N1) [11], against herpes 
simplex virus type-1 (HSV-1) and hepatitis-A 
virus (HAV) [12], serotonin 5-HT6 receptor 
antagonist [13]. Heterocyclic compounds were 
reported as inhibitors of glycogen synthase 
kinase-3(GSK-3) and potent anti-tumor agents 
[14-15]. As an extension of our ongoing studies, 
the objective of the present work is to synthesis 
a series of TPYD derivatives and evaluates 
them both in vitro and in vivo for their 
anthelmintic activities against experimental E. 





2-Amino naphthalino [1,2-d]thiazolo, 
compound 2 
 
A mixture of compound 1 (0.01 mol) and KSCN 
(0.01 mol) in acetic acid (50 ml) was placed in 
freezing mixture and stirred mechanically with 
addition of Br2 (0.2 mol) for 2 h at 0 - 10 0C. The 
reaction mixture was poured onto ice-water, the 
formed solid product was collected by filtration, 
washed with water, dried and crystallized from 





















Scheme 1: Synthesis of compounds 2 – 4 
 
2-Diazo naphthalino [1,2-d]thiazolo, 
compound 3 
 
A stirred solution of compound 2 (0.01 mol) in 35 
% HCL (10 ml) was diazotized at 0 - 5 0C by a 
solution of 30 % aq. NaNO2. Then, the solution 
poured onto ice water and the solid product was 
crystallized from ethanol to give compound 3 as 
yellow powder.  
 
2-Hydrazino naphthalino [1,2-d]thiazolo, 
compound 4 
 
A mixture of diazonium salt 3 (0.01 mol) and 
stannous chloride (0.01 mol) in concentrated 
hydrochloric acid (40 ml) was stirred over night 
at room temperature. After cooling (-10 0C), the 
obtained solid was filtered off, washed with 
water, dried, and crystallized from the ethanol to 
give compound 4 as brown powder.  
 
A solution of compound 2 (0.01 mol) in DMF (20 
ml) was added benzylidine ethyl cyano acetate 
(0.01 mol) and piperidine (2 drops) refluxed 3 h, 
the solvent was evaporated under reduced 
pressure and the remaining product was 
triturated with water and acidified with conc. 
HCL. After filtration the separated solid was 
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collected and crystallized from ethanol to give 
















5                            6 
Scheme 2: Synthesis of compounds 5 and 6 
 
3,5-Dioxo-4H-pyrimidino [3,2-b]naphthalino 
[1,2-d] thiazolo, compound 6 
 
A mixture of compound 2 (0.1 mol) and diethyl 
malonate  (0.1 mol)  in glacial acetic acid (30 
ml), in the presence of few drops tri-ethyl-amine, 
was refluxed for 3 h. The reaction mixture was 
poured into water; the separated solid was 
collected and crystallized from ethanol to give 
compound 6 as green powder. 
 
Elemental and spectral analysis 
 
Melting points were determined on open glass 
capillaries using Electro thermal IA 9000 digital 
melting point apparatus (Electro thermal, Essex, 
UK.) and are uncorrected. Elemental analyses 
were performed with all final compounds on 
Elementar, Vario EL, Micro Analytical Unit, 
National Research Centre, Cairo, Egypt and 
were found within ~ 0.4 % of the theoretical 
values. Analytical data were obtained from the 
Micro analytical Unit, Cairo University, Egypt. 
The IR spectra (KBr) were recorded on a FT IR-
8201 PC spectrophotometer. The 1H-NMR 
spectra was measured with Jeol FTGNM-EX 
270, 270 MHz instrument in DMSO-d6 and the 
chemical shifts were recorded in (δ, ppm) 
relative to TMS. The mass spectra were run at 
70 eV with a Finnigan SSQ 7000 spectrometer 
using EI and the values of m/z are indicated in 
Dalton. TLC (Silica gel, aluminum sheets 60F254, 
Merck, Darmstadt, Germany) followed the 
reactions. 
 
Culture of E. multilocularis metacestodes  
 
Six weeks old female BALB/c mice, 16-18 g 
each were used. Approval of the institutional 
animal ethical committee for animal studies was 
obtained from the Office of Environmental 
Health and Radiation Safety, ACUC protocol # 
1096-5. Animals were housed in a temperature-
controlled, light cycle room in animal facilities 
according to American and European federal 
animal protection guidelines, with food and 
water ad libitum. In vitro cultivation of E. 
multilocularis metacestodes was carried out as 
previously described [16]. Briefly, mice were 
infected intraperitoneally with E. multilocularis 
clone KF5. After 2-3 months, the animals were 
euthanized and the parasite tissue was 
recovered from the peritoneal cavity under a 
septic conditions. The tissue pieces were cut 
into small tissue blocks (0.5 - 1 cm3), and 
several pieces of tissue were placed in 75 ml of 
culture medium (RPMI) 1640 containing 25 mM 
HEPES, 4 mM L-glutamine, 100 U of 
Penicillin/ml and 100 µg of Streptomycin/ml) 
supplemented with 10% fetal calf serum (FCS) 
and phenol red. Tissue blocks were kept in 
tightly closed culture flasks (200 ml) placed in an 
upright position in an incubator at 37 0C with 5% 
CO2, with medium change every week. These 
metacestodes were used for in the vitro 
compounds assays as described below. The 
synthetic compounds were dissolved in DMSO 
(stock solution of 10 mM). Albendazole was 
purchased from Sigma Aldrich (St. Louis, MO, 
USA). All tissue culture media and biochemical 
reagents were purchased from Invitrogen 
(Basel, Switzerland).  
 
In vitro metacestodes treatment, growth 
assays, histological studies and 14-3-3 
protein mRNA PCR quantitation  
 
Free floating metacestodes with diameters 
between 1 and 5 mm were harvested, washed 3 
times in serum free medium and divided into 
separate cultures in 15 ml of RPMI medium 
without FCS and phenol red. The tested 
compounds were added to the cultures 
separately, yielding final concentration of 2, 5 
and 10 µM. Control cultures were performed 
with corresponding amounts of DMSO alone. 
Treatment was carried out at 37 oC/CO2 for 7 
days. At day 7, metacestodes were processed 
for in vitro compounds assays using light 
microscopy, scanning and transmission electron 
microscopy (SEM/TEM) as described by [17]. 
Also, the relative quantification of 14-3-3 mRNA 
expression was performed. Briefly, the total RNA 
was extracted employing the RNeasy mini kit 
(Qiagen). The total RNA was used to synthesize 
cDNA using Omnitranscriptase kit (Qiagen). 
Quantitative real-time PCR was performed using 
the LightcyclerTM instrument (Roch) with primers 
and conditioned established for quantitation of 
14-3-3 and actin-transcripts as previously 
described [18].  
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Bioassay of E. multilocularis metacestodes 
viability in mice 
 
In order to investigate in vitro compounds-
treated metacestodes for viability or non-viability, 
mice (8 animals per group), were infected by 
intraperitoneal injection of 100 µl metacestodes 
suspension. Before inoculation, the suspension 
had been prepared by isolation of parasite 
metacestodes tissue from mice as described 
above. The parasite tissue was pressed through 
a sterile metal sieve and the obtained 
suspension was distributed to five culture flasks 
containing 10 ml culture medium with FCS and 
phenol red. Treatment of the culture was as 
follows: (i) 10 µM TPYDa (ii) 30 µM ABZ (iii) a 
combination of 10 µM TYPYDa/30 µM ABZ and 
(iv) DMSO alone as a control. Medium was 
changed with addition of fresh drugs on days 5 
and 10. On day 14, all suspensions were 
concentrated by short centrifugation and used 
for mice infection. At 15 weeks post-inoculation, 
mice were sacrificed, dissected, parasite tissue 
removed from the peritoneal cavity and the 
parasite weight was determined as previously 
described [19]. Before animal sacrificed, 
heparinized blood was collected by heart 
puncture and plasma levels for analine 
aminotransferase (ALT) and aspartate 
aminotransferase (AST) were measured using 
mice kits, according to routine clinical chemical 
methods (Department of Clinical Chemistry, 
Maternity and Children's Hospital, Medina 




This was carried out using SPSS, version 8.0 
software. Statistical significance was determined 
using one-way analysis of variance (ANOVA) 






2-Amino naphthalino [1,2-d]thiazolo, 
compound 2 
 
Yield 68 %; mp 285 0C; IR (KBr, cm-1): 3285 
(NH2); 1H-NMR (DMSO-d6): δ: 6.14 (s, 2H, NH2, 
exchangeable with D2O),7.12-7.38 (m,6H,ArH) 
ppm; MS m/z (%) 200(M+,23) corresponding to 
the molecular formula C11H8N2S and at 184 
(100, base peak). 
 
2-Diazo naphthalino [1,2-d]thiazolo, 
compound 3 
 
Yield 67%; mp 248 oC; IR (KBr, cm-1): 1615-
1430(C=N,C=C,Ar);1H-NMR (DMSO-d6): 6.92-
7.41(m,6H,Ar-H)ppm; MS m/z (%): 212(M+,38) 
corresponding to the molecular formula 
C11H6N3S and at 126 (100, base peak). 
 
2-Hydrazino naphthalino [1,2-d]thiazolo, 
compound 4 
 
Yield 79 %; mp 262 0C; IR (KBr, cm-1): 3340-
3280 (NH, NH2); 1H-NMR (DMSO-d6) : 5.67 
(s,1H,NH, exchangeable with D2O), 7.12-7.65 
(m,6H,Ar-H), 10.31 (b, 2H,NH2, exchangeable 
with D2O) ppm; MS m/z (%):MS m/z (%): 215 
(M+, 21) corresponding to the molecular formula 
C11H9N3S and at 132 (100, base peak).  
 
3-Amino-4-ethoxy carbonyl-5-(4-chloro 
phenyl) pyrimidino[3,2-b]naphthalino [1,2-d] 
thiazolo, compound 5 (TPYDa) 
 
Yield 62%; mp 225 0C; IR (KBr, cm-1): 3270 
(NH2), 1730(C=O ester); 1H-NMR (DMSO-d6) : 
2.14 (t, 3H, CH3), 3.28 (q, 2H, CH2), 6.84-7.25 
(m, 6H, ArH), 7.54-7.87 (m, 5H, ArH), 10.31 (br, 
2H, NH2 exchangeable with D2O) ppm;  MS m/z 
(%): 436 (M+, 42) corresponding to the 
molecular formula C23H18N3SO2CL and at 235 
(100, base peak). 
 
3,5-Dioxo-4H-pyrimidino [3,2-b]naphthalino 
[1,2-d] thiazolo, compound 6 (TPYDb) 
 
Yield 64 %; mp 297 0C; IR (KBr,cm-1): 1690(C=O 
amid); 1715(C=O amid);1H-NMR (DMSO-d6)δ: 
7.14-7.52(m,6H,ArH)ppm; MS m/z(%): 
268(M+,31) corresponding to the molecular 





As shown in (Table 1), The results of 
metacestodes growth after in vitro cultures of E. 
multilocularis metacestodes treatment with 
different concentrations  indicate that parasite 
tissue developed in all animals infected with 
metacestodes from cultures treated with 1, 2 
and 5 µM of all compounds, except only TPYDa 
compound achieved best result at 2 and 5 µM 
concentrations. In contrast, animals infected with 
metacestodes from cultures treated with 10 µM 
of the compounds, the parasite growth was 
absent.  SEM/TEM histology studies correlate 
with this observation (data not shown).  
 
   Table 1: Growth of E. multilocularis metacestode following in vitro treatment with synthetic compounds (2 – 6)  
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Growth of metacestodes 
TPYD 
concentration DMSO* Compound 2 Compound 3 Compound 4 Compound 5     (TPYDa) 
Compound 6  
  (TPYDb) 
1 µM    +     +     +     +     +     + 
2 µM    +     +     +     +     +/-     + 
5 µM    +     +     +     +     -     + 
10 µM    +     -     -     -     -     - 
    *Control group was inoculated E. multilocularis metacestodes-treated with the solvent, DMSO, alone. 
 
Table 2: Recovery of parasite weights (value in g) from mice after bioassay, following 
inoculation of E. multilocularis metacestodes-treated in vitro with ABZ, TPYDa and 











30 µM/10 µM 
1 1.8 ± 0.008 0 0.2 ± 0.008 0 
2 2.6 ± 0.09 0 3.0 ± 0.9 0 
3 1.0 ± 0.002 2.2 ± 0.08 1.5 ± 0.006 0.8 ± 0.007 
4 2.0 ± 0.09 1.8 ± 0.009 0 0.3 ± 0.009 
5 1.9 ± 0.008 3.0 ± 0.2 2.0 ± 0.06 0.05 ± 0.006 
6 3.4 ± 0.5 0.6 ± 0.001 0.4 ± 0.009 0.9 ± 0.008 
7 2.2 ± 0.07 2.4 ± 0.09 2.3 ± .06 0.005 ± 0.0001 
8 3.2 ± 0.2 1.6 ± 0.008 1.6 ± 0.009 0.5 ± 0.009 
*Control group was inoculated E. multilocularis metacestodes-treated with the solvent, DMSO, alone 
 
Inhibition of 14-3-3 mRNA expression  
 
It was earlier demonstrated that in E. 
multilocularis metacestodes 14-3-3 gene 
expression relative to actin, as an indicator for 
parasite viability. β-actin-expression was used as  
reference to normalize the samples. The effect 
on the relative 14-3-3 expression was dose 
dependent. TPYDa compound at 2 µM 
concentration , 14-3-3 expression levels were 
reduced by one third, while 5 and 10 µM 
concentrations reduced the levels of 14-3-3 
transcripts down to approximately 66 – 88 % of 




Figure 1: TPYDa treatment of E. multilocularis 
metacestodes 14-3-3 mRNA   expression. 
Metacestodes were treated with 2 µM, 5 µM and 10 
µM for 7 days, and transcription of the 14-3-3 gene 
was quantified in relation to actin by real-time PCR. 
Values in the y-axis indicate the ratio between 14-3-3 




Growth of metacestodes in mice 
 
Incubation of metacestodes vesicles suspension 
with DMSO for 14 days, followed by infection of 8 
mice and recovery of parasite material after 15 
weeks resulted in a pronounced growth of E. 
multilocularis metacestodes, yielding parasite 
masses ≥ 1 g for all mice (range, 1.0 - 3.4 g). 
TPYDa treatment alone showed fair improvement 
(~ 60 %) in relation to ABZ (~ 63 %). However, 
combined treatment (TPYDa/ABZ) resulted in 
consistently lower parasite weights (~ 86 %) 
relative to the control group and in all mice, the 
parasite weight was considerably < 1 g (Table 2). 
However, a complete parasitocidal effect was not 
achieved with any of these treatments. The 
safety of TPYD compounds and ABZ- treated E. 
multilocularis metacestodes suspensions on mice 
hepatic injury and hepatocytes damage was 
assessed by measuring serum levels of ALT and 
AST. No significant difference in serum levels of 
ALT and AST was noticed in all mice before 
sacrifice compared to the control (Table 3). 
 
Table 3: Effect of synthesized compounds treatment 
on mice hepatocyte markers ALT and AST 
 
 Treatment ALT(U/L) AST(U/L) 
10 µM TPYDa 37.2 ± 0.3 33.2 ± 0.3 
30 µM ABZ 34.8 ± 0.5 31.9 ± 0.4 
10 µM TPYDa/30 µM ABZ 35.9 ± 0.4 34.3 ± 0.2 
*No significant difference between all mice relative to control 
(p ‹ 0.05) 
 
DISCUSSION 
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In previous work we have reported the synthesis 
of thiazolo derivatives used α-amino naphthol 1. 
The reaction of compound 1 with KSCN afforded 
2-amino thiazolo derivatives 2. The reaction of 
compound 2 with sodium nitrite and hydrochloric 
acid afforded the corresponding thiazolo 
derivatives 3, which converted to 2-hydrazino 
thiazolo derivatives 4 (Scheme 1). Reaction of 
hydrazino thiazolo derivatives 4 with benzylidine 
derivatives afforded pyrimidino thiazolo 
derivative 5. Also, hydrazino thiazolo derivatives 
4 was reacted with diethyl malonate to afford 
pyrimidino thiazolo derivative 6 (Scheme 2). All 
the synthesized compounds were confirmed by 
spectral data (IR, 1H-NMR and mass spectra). 
Structure activity relationships based on the 
obtained results indicated that, substitution of 3–
Amino–4-ethoxy carbonyl pyrimidino thiazolo 
derivatives had anti proliferative growth effect of 
E. multilocularis metacestodes. 
 
We initially investigated whether the new 
synthetic TPYD treatment would affect 14-3-3 
mRNA expression in E. multilocularis 
metacestodes. In our work, 14-3-3 transcript 
levels were reduced by one third upon treatment 
with 2 µM concentration of the compound and 
more drastically reduced upon treatment with 5 
µM and 10 µM concentrations. This dose 
dependent reduction in 14-3-3 expression levels 
especially at higher concentrations, was 
accompanied by completely distorted germinal 
layer-associated parasite tissue with major 
morphological and ultra structural changes seen 
by SEM/TEM (data not shown). There is an 
association between the uncontrolled 
proliferation and the over-expression of a family 
of proteins named 14-3-3 proteins in 
echinococcus metacestodes. This suggests that 
treatments interfering with 14-3-3-protein-
expression and/or function could interfere with 
the growth of the metacestodes [4]. Our results 
showed the inhibition effect of TPYD compounds 
on E. multilocularis metacestodes tumor-like 
proliferation was in consistence with previous 
results showed that hetero-cyclic compounds 
were potent anti-tumor agents [14,15]. 
 
Compound TPYDa showed potent anthelmintic 
activity and emerged as the most active agent of 
the synthetic compounds that might be due to 
the presence of electron-donating moiety which 
increased the pharmacological activity and it 
was moderately more potent as the traditional 
anthelmintic drug ABZ. When TPYDa combined 
with ABZ, increased the cure rate of E. 
multilocularis metacestodes treatment. In the 
future, this combination treatment could 
minimize the high recurrence rate of 




The study shows synthetic heterocyclic organic 
compounds, a new series of substituted amino 
thiazole, hydrazinothiazole and thiazolo 
pyrimidine derivatives (2-6), are promising 
candidates for the development of new 
anthelmintic agents with rapid regeneration and 
hepatic physiological and pathological functional 
reformation of damaged compressed liver tissue 
caused by the tumor-like infiltrative growth of the 
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